Deeptankar Demazumder is a Cardiology physician. OpenAlex indexes 63 publications with 1,110 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
234 Goodman St
Cincinnati, OH 452192364
Telephone
513-475-8521Registry record last updated 21 Jun 2017.
Clinical trials
- Relaxin Therapy for Atrial Fibrillation
Sponsor: Deeptankar DeMazumder
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BIOTRONIK INC.Program year202517 payments
- BIOTRONIK INC.Program year20247 payments
- BIOTRONIK INC.Program year20235 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
64.3%Beta blocker64.3%Metoprolol Succinate100%Part D<11 patientsBlood & clotting
35.7%Factor Xa inhibitor35.7%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2017–2020 per NIH RePORTER. The latest:
- Eavesdropping on heart-brain conversations during sleep for early detection and prevention of fatal cardiovascular disease
University of Cincinnati
FY2020$185,830DP2HL157941 - Autonomic remodeling and modulation therapy in heart failure and sudden death
University of Cincinnati
FY2019$248,996R00HL130662 - Autonomic remodeling and modulation therapy in heart failure and sudden death
University of Cincinnati
FY2018$249,000R00HL130662
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”